Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Transplantation
|
October 27, 1994
Attempted resolution of acute recurrent hepatitis B in a transplanted liver allograft by the administration of ganciclovir
E M Yoshida, R A Wolber, W A Mahmood, et al.
The American Journal of Surgical Pathology
|
January 1, 1991
Hepatic hemangioblastoma. An unusual presentation in a patient with von Hippel-Lindau disease
A M Rojiani, D A Owen, K Berry, et al.
Lancet (London, England)
|
May 12, 2005
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
A M Grant, A Avenell, M K Campbell, et al.
Gut
|
April 11, 2006
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
G Van Assche, W J Sandborn, B G Feagan, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Transplantation
|
October 27, 1994
Attempted resolution of acute recurrent hepatitis B in a transplanted liver allograft by the administration of ganciclovir
E M Yoshida, R A Wolber, W A Mahmood, et al.
The American Journal of Surgical Pathology
|
January 1, 1991
Hepatic hemangioblastoma. An unusual presentation in a patient with von Hippel-Lindau disease
A M Rojiani, D A Owen, K Berry, et al.
Lancet (London, England)
|
May 12, 2005
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
A M Grant, A Avenell, M K Campbell, et al.
Gut
|
April 11, 2006
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
G Van Assche, W J Sandborn, B G Feagan, et al.
Page
of 5